MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.

VERV Verve Therapeutics Forecast, Technical & Fundamental Analysis

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
Related Blogs
CANF

CANF and ICU: Contrasting Clinical Biotech Catalysts with Medical Device Commercialization

RVMD

Monte Rosa Therapeutics (GLUE) and Revolution Medicines (RVMD): Contrasting Biotech Journeys in 2026

NVAX

NVAX vs PDSB: Contrasting Biotech Strategies in Licensing and Clinical Development

PFE

ENLV vs PFE: Exploring Two Distinct Risk Profiles in Healthcare

JAZZ

Jazz Pharmaceuticals (JAZZ) Delivers +48% YTD Gains While Pacira BioSciences (PCRX) Enters Acquisition Talks

View all blogs related to
#Biotechnology
Interesting Articles

What should I compare the performance of my portfolio with?

How volatile are commodities?

What are the Contribution Deadlines for My SEP IRA?

How Can I Keep My Health Costs Down in Retirement?

What is a foreign transaction fee?

View all articles
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.561.28
+5.06%
GameStop Corp
TSLA382.707.70
+2.05%
Tesla
BTC.X83679.470000767.242200
+0.93%
Bitcoin cryptocurrency
SPY778.574.64
+0.60%
State Street SPDR S&P 500 ETF (SPY)
AAPL336.64-3.78
-1.11%
Apple
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com
Verve Therapeutics (VERV) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com